These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 22250481)

  • 1. Factor V Leiden mutation and its impact on pregnancy complications.
    Hammerová L; Chabada J; Drobný J; Bátorová A
    Acta Medica (Hradec Kralove); 2011; 54(3):117-21. PubMed ID: 22250481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus.
    Dizon-Townson D; Miller C; Sibai B; Spong CY; Thom E; Wendel G; Wenstrom K; Samuels P; Cotroneo MA; Moawad A; Sorokin Y; Meis P; Miodovnik M; O'Sullivan MJ; Conway D; Wapner RJ; Gabbe SG;
    Obstet Gynecol; 2005 Sep; 106(3):517-24. PubMed ID: 16135581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pregnancy outcomes in a patient-heterozygous carrier of R506Q mutation of factor V (Leiden)].
    Herman M; Djelmis J; Troselj Z; Ivanisević M
    Acta Med Croatica; 2006 Jun; 60(3):277-80. PubMed ID: 16933843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripartum thromboprophylaxis for homozygous and heterozygous FVL mutation carriers yields similar pregnancy outcome.
    Gat I; Dulitzki M; Schiff E; Sivan E; Simchen MJ
    Isr Med Assoc J; 2014 Feb; 16(2):96-100. PubMed ID: 24645228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of factor V leiden and prothrombin gene mutation and placenta-mediated pregnancy complications: a systematic review and meta-analysis of prospective cohort studies.
    Rodger MA; Betancourt MT; Clark P; Lindqvist PG; Dizon-Townson D; Said J; Seligsohn U; Carrier M; Salomon O; Greer IA
    PLoS Med; 2010 Jun; 7(6):e1000292. PubMed ID: 20563311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of placenta-mediated pregnancy complications or pregnancy-related VTE in VTE-asymptomatic families of probands with VTE and heterozygosity for factor V Leiden or G20210 prothrombin mutation.
    Cordoba I; Pegenaute C; González-López TJ; Chillon C; Sarasquete ME; Martin-Herrero F; Guerrero C; Cabrero M; Garcia Sanchez MH; Pabon P; Lozano FS; Gonzalez M; Alberca I; González-Porras JR
    Eur J Haematol; 2012 Sep; 89(3):250-5. PubMed ID: 22642978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased activation of blood coagulation in pregnant women with the Factor V Leiden mutation.
    Kjellberg U; van Rooijen M; Bremme K; Hellgren M
    Thromb Res; 2014 Oct; 134(4):837-45. PubMed ID: 25135795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of factor V Leiden, prothrombin and methylenetetrahydrofolate reductase gene mutations in patients with severe pregnancy complications in northern Finland.
    Jarvenpaa J; Pakkila M; Savolainen ER; Perheentupa A; Jarvela I; Ryynanen M
    Gynecol Obstet Invest; 2006; 62(1):28-32. PubMed ID: 16514238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placenta-mediated pregnancy complications are not associated with fetal or paternal factor V Leiden mutation.
    Nevalainen J; Ignatius J; Savolainen ER; Ryynanen M; Jarvenpaa J
    Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():32-35. PubMed ID: 30243226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Does the asymptomatic carriage of FV Leiden and FII prothrombin in heterozygous configuration represent the increased risk of thrombembolic complications during pregnancy, childbirth and postpartum?].
    Binder T; Vavrinková B; Hadacová I; Hrachovinová I; Salaj P; Hruda M
    Ceska Gynekol; 2012 Feb; 77(1):25-30. PubMed ID: 22536637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of factor V Leiden in maternal health and the outcome of pregnancy.
    Calderwood CJ; Greer IA
    Curr Drug Targets; 2005 Aug; 6(5):567-76. PubMed ID: 16026277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated protein C resistance -- in the absence of factor V Leiden -- and pregnancy.
    Lindqvist PG; Svensson P; Dahlbäck B
    J Thromb Haemost; 2006 Feb; 4(2):361-6. PubMed ID: 16420566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy-associated risk for venous thromboembolism and pregnancy outcome in women homozygous for factor V Leiden.
    Pabinger I; Nemes L; Rintelen C; Koder S; Lechler E; Loreth RM; Kyrle PA; Scharrer I; Sas G; Lechner K; Mannhalter C; Ehrenforth S
    Hematol J; 2000; 1(1):37-41. PubMed ID: 11920167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor V Leiden mutation and pregnancy-related complications.
    Kjellberg U; van Rooijen M; Bremme K; Hellgren M
    Am J Obstet Gynecol; 2010 Nov; 203(5):469.e1-8. PubMed ID: 21055512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal and neonatal outcome of preeclamptic pregnancies: the potential roles of factor V Leiden mutation and 5,10 methylenetetrahydrofolate reductase.
    Rigó J; Nagy B; Fintor L; Tanyi J; Beke A; Karádi I; Papp Z
    Hypertens Pregnancy; 2000; 19(2):163-72. PubMed ID: 10877984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The frequency of venous thromboembolism in women with Leiden mutation in association with pregnancy and puerperium].
    Dulícek P; Malý J; Kalousek I; Beránek M; Pecka M
    Ceska Gynekol; 2005 Mar; 70(2):133-8. PubMed ID: 15918268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor V Leiden and prothrombin G20210A gene mutations in women with a history of thrombosis during pregnancy. Relation to pregnancy outcomes for mother and fetus.
    Abu-Skeen IA; Mohamed AA; Moustafa NN; Badawy ME
    Saudi Med J; 2010 Feb; 31(2):123-9. PubMed ID: 20174725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal evaluation of markers of hemostasis in pregnancy.
    Hammerova L; Chabada J; Drobny J; Batorova A
    Bratisl Lek Listy; 2014; 115(3):140-4. PubMed ID: 24579682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor V Leiden in pregnancies complicated by placental abruption.
    Procházka M; Happach C; Marsál K; Dahlbäck B; Lindqvist PG
    BJOG; 2003 May; 110(5):462-6. PubMed ID: 12742330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective screening for the Factor V Leiden mutation: is it advisable prior to the prescription of oral contraceptives?
    Schambeck CM; Schwender S; Haubitz I; Geisen UE; Grossmann RE; Keller F
    Thromb Haemost; 1997 Dec; 78(6):1480-3. PubMed ID: 9423798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.